{
    "medicine_id": "3c2c6f7caaa1cab66e230d67de0343682f065795",
    "platform_id": "DB00659",
    "metadata": {
        "name": "Acamprosate Calcium 333 mg 1 Tablet coated",
        "composition": "333 mg 1 Acamprosate",
        "clinical_particulars": {
            "therapeutic_indications": "For the maintenance of abstinence from alcohol in patients with alcohol dependence who are abstinent at treatment initiation",
            "contraindications": {
                "disease": "In all reported cases of acute overdosage with acamprosate total reported doses of up to 56 grams of acamprosate calcium the only symptom that could be reasonably associated with acamprosate was diarrhea",
                "pregnancy": "NA",
                "machine_ops": "NA",
                "pharmacodynamics": "Pharmacodynamic studies have shown that acamprosate calcium reduces alcohol intake in alcohol dependent animals in a dose dependent manner and that this effect appears to be specific to alcohol and the mechanisms of alcohol dependence Acamprosate calcium has negligible observable central nervous system CNS activity in animals outside of its effects on alcohol dependence exhibiting no anticonvulsant antidepressant or anxiolytic activity",
                "excipients": "NA",
                "incompatibilities": []
            }
        },
        "revision_date": "2023-05-14"
    }
}